Skip to main content
Clinical Trials/NCT01760668
NCT01760668
Completed
Not Applicable

Aortopathy in Persons With Bicuspid Aortic Valve, Turner and Marfan Syndrome

University of Aarhus1 site in 1 country5 target enrollmentFebruary 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Turner Syndrome
Sponsor
University of Aarhus
Enrollment
5
Locations
1
Primary Endpoint
DNA-methylations of CpG-islands
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The study aim is:

  1. To examine aortic tissue by light microscopy
  2. To examine aortic tissue by electron microscopy
  3. To study changes in the epigenome and transcriptome of the X chromosome specific to aortic tissue.
  4. To examine aortic tissue using biochemistry including proteomics.
  5. To establish the karyotype of fibroblasts with standard chromosome examination on 10 meta-phases as well as by fluorescent in situ hybridization (FISH) with probes covering the X and Y chromosome. Using the latter 200 meta-phases will be examined.

30 controls who did not die from aortic dissection or dilation will be recruited from The Department of Forensic Medicine at Aarhus University Hospital.

The investigators will subject samples of aortic tissue from women undergoing prophylactic aortic surgery due to either Marfan syndrome or bicuspid aortic valve to the same panel of examinations (except karyotyping). Lastly the investigators will compare the results from the three groups (Turner syndrome, Marfan syndrome and Bicuspid aortic valve).

Detailed Description

Turner syndrome is a congenital complete or partial lack of one of the female sex chromosomes affecting 1 of 2000 live born girls. The syndrome is characterized by an increased prevalence of ischemic heart disease, aortic dilation and dissection, hypertension, stroke and autoimmune diseases in general.

Registry
clinicaltrials.gov
Start Date
February 2013
End Date
October 2015
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

DNA-methylations of CpG-islands

Time Frame: Cross sectional

mapping DNA-methylations of CpG-islands

Histone modifications

Time Frame: Cross sectional

Permissive and repressive histone modifications on the X-chromosome

mRNA and non-coding RNAs

Time Frame: Cross sectional

Identification of the entire transcriptome including both mRNA and non-coding RNAs (lincRNA as well as miRNA)from the X-chromosome

Karyotyping by FISH and conventional karyotyping

Time Frame: Cross sectional

Proteomics

Time Frame: Cross sectional

Electron microscopic evaluation

Time Frame: Cross sectional

Study Sites (1)

Loading locations...

Similar Trials